Findings can lead to gut replacement therapy in people with intestinal deficiencies
Working with gut stem cells from humans and mice, scientists from the Johns Hopkins Children’s Center and the University of Pittsburgh have successfully grown healthy intestine atop a 3-D scaffold made of a substance used in surgical sutures.
In a further step that takes their work well beyond proof of concept, researchers report their laboratory-created intestine successfully regenerated gut tissue in the colons of dogs with missing gut lining.
The experiments, described ahead of print in the journal Regenerative Medicine, bring researchers closer to creating an implantable intestine as replacement therapy for a range of devastating disorders – including infections, cancer and trauma – that result in loss or death of gut tissue. Chief among them is a condition that affects 12 percent of premature newborns, called necrotizing enterocolitis (NEC), which is marked by the rapid death of intestinal cells and permanent loss of intestinal tissue.
The tube-shaped scaffold, designed several years ago in collaboration with Cornell University researchers and composed of biodegradable material similar to that used in surgical sutures, was a big first step on the quest to develop an implantable replacement intestine. But the new work pushes that effort further because it shows how stem cells, when mixed with immune and connective tissue cells, can grow into normal gut tissue around the scaffold and function inside a living mammal.
Researchers caution that a fully functioning replacement intestine for humans is far off, but they say their results have laid the critical groundwork to do so.
“Our experiments show that the architecture and function of our lab-made intestine strikingly resemble those of the healthy human gut, giving us real hope that our model could be used as the backbone for replacement intestine,” says principal investigator David Hackam, M.D., Ph.D., the Johns Hopkins Children’s Center’s surgeon-in-chief, who initiated and conducted most of the work at the University of Pittsburgh.
In an initial set of experiments reminiscent of a peanut butter-and-jelly sandwich technique, researchers took stem cells from the colons of babies undergoing intestinal surgeries and from mice, then added immune cells called macrophages, the body’s scavengers that seek out and engulf debris along with foreign and diseased cells. To this mix, they added cells called fibroblasts, whose function is to form collagen and other connective substances that bind tissues and organs together. The idea, the scientists say, was to create a mixture that closely mimics the natural composition of the gut.
“Intestinal cells do not grow and develop in a vacuum, so we sought to recreate the richness of the human gut, Hackam says. “We took the PB & J approach, adding a layer of stem cells on top of the scaffold, then topping them with a mixture of immune and collagen cells.”
Adding these components, they report, enhanced the growth of intestinal stem cells and differentiation into various mature cell types critical to the function of a healthy intestine. In comparison, stem cells grown in isolation without immune and connective cells in the mix grew more slowly and failed to differentiate well into multiple cell types.
In another set of experiments, researchers added probiotic bacteria to the newly created intestinal tissue. Doing so further amplified the growth and differentiation of new gut cells, specifically the growth of Paneth cells responsible for production of infection-fighting proteins that guard against intestinal infections, Hackam says, a finding that highlights the therapeutic potential of certain probiotics for NEC. Next, the team added bacteria-laden stool cells obtained from infants with NEC, but they observed a dramatic decrease in the number of intestinal cells called goblet cells, which are responsible for the production of protective mucus that coats and shields the intestine – a common occurrence in NEC. The observation, Hackam says, supports the notion that certain gut bacteria present in the colons of babies with NEC are responsible for sparking the rapid death of gut tissue that occurs in the condition.
Next, researchers implanted the newly created intestine into the bellies of mice. In a matter of days, the implanted intestine began producing new intestinal stem cells and stimulated the growth of new blood vessels around the implant. That observation, researchers say, affirmed the ability of the 3-D intestine to spur the growth of new tissue not only in lab dishes, but also in living organisms.
In a final step, the investigators implanted pieces of the newly created intestine – about 1.6 inches in length – into the lower portion of dog colons lacking parts of their intestinal lining. For two months, the dogs underwent periodic colonoscopies and intestinal biopsies. Strikingly, the guts of dogs with implanted intestines healed completely within eight weeks. By contrast, dogs that didn’t get intestinal implants experienced continued inflammation and scarring of their guts.
The Latest on: Regenerative medicine
via Google News
The Latest on: Regenerative medicine
- Institute for Regenerative Medicine is Helping Men Wave Goodbye to Erectile Dysfunction with Cutting-edge GAINSWave® Treatment on April 17, 2019 at 4:00 am
CLAYTON, Mo., April 17, 2019 /PRNewswire/ -- Brij Vaid, MD with institute for Regenerative medicine is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This ... […]
- RepliCel Secures Several New Patents for its Regenerative Medicine Technologies on April 16, 2019 at 5:41 pm
Tendon Regeneration, Skin Rejuvenation and Dermal Injector Patents Granted in the United States, Europe, South Africa, Hong Kong, China, and Japan VANCOUVER, April 16, 2019 /PRNewswire/ - RepliCel ... […]
- 'This is the most complicated process I’ve ever seen': As billions flow into the hottest new area of medicine, top execs say a crisis is brewing on April 15, 2019 at 7:48 am
Manufacturing is such a broad problem that industry group Alliance for Regenerative Medicine (ARM) is working on a how-to guide spelling out the process, which it's calling "A-Gene." The group was ... […]
- Everything to know about stem cell regenerative injection therapy on April 15, 2019 at 3:06 am
Regenerative medicine may be a good option to help repair damaged or injured tissues, such as in your knee, shoulder or hip. (Photo: Getty Images) Regenerative medicine can repair damaged or injured ... […]
- Regenerative medicine to fuel demand for stem cell specialists on April 15, 2019 at 2:42 am
Professional programmes in Regenerative Medicine will help the students in devising new methods for the treatment of degenerative diseases, writes Shruti Niraj Regenerative medicine is the most ... […]
- Regenerative Medicine market Size Soaring at 23.5% CAGR to reach USD 19000 million by 2024 on April 12, 2019 at 10:22 am
Apr 12, 2019 (Heraldkeeper via COMTEX) -- The 'Regenerative Medicine market' analytical summative by Market Study Report, LLC, is a thorough study on the latest market trends prevailing in the global ... […]
- Mallinckrodt Completes Full Enrollment of its Phase 3 Clinical Trial for StrataGraft® Regenerative Skin Tissue on April 12, 2019 at 3:56 am
The FDA has granted StrataGraft orphan drug status, and it was also among the first products designated by the Agency as a Regenerative Medicine Advanced Therapy under the provisions of the 21st ... […]
- Wake Forest Institute of Regenerative Medicine director explains FDA crackdown on stem cell facilities on April 10, 2019 at 9:24 am
Earlier this month, 21 stem cell clinics and manufacturers across the country received warnings from the U.S. Food and Drug Administration, part of an ongoing crackdown on marketing and selling ... […]
- Global Regenerative Medicine Market Forecast to 2024: Product Approvals and Growing Pipeline of Regenerative Medicine Products on April 10, 2019 at 8:15 am
DUBLIN, April 10, 2019 /PRNewswire/ -- The "Regenerative Medicine Market by Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], ... […]
- Regenerative medicine market to register a CAGR of 23.8% on April 8, 2019 at 3:02 pm
NEW YORK, April 8, 2019 /PRNewswire/ -- Regenerative medicine market to register a CAGR of 23.8% from 2019 to 2024 The regenerative medicine market is projected to reach USD 38.7 billion by 2024 from ... […]
via Bing News